sevoflurane has been researched along with Mucopolysaccharidosis III in 1 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamata, M | 1 |
| McKee, C | 1 |
| Truxal, KV | 1 |
| Flanigan, KM | 1 |
| McBride, KL | 1 |
| Aylward, SC | 1 |
| Tobias, JD | 1 |
| Corridore, M | 1 |
1 other study available for sevoflurane and Mucopolysaccharidosis III
| Article | Year |
|---|---|
General anesthesia with a native airway for patients with mucopolysaccharidosis type III.
Topics: Adolescent; Airway Management; Anesthesia, General; Anesthetics, Intravenous; Child; Child, Preschoo | 2017 |